Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
Meta Platforms (Facebook)
META
|
+$446M |
| 3 |
Johnson & Johnson
JNJ
|
+$306M |
| 4 |
Evergy
EVRG
|
+$288M |
| 5 |
Walmart Inc
WMT
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Home Depot
HD
|
+$596M |
| 2 |
Booking.com
BKNG
|
+$519M |
| 3 |
Amazon
AMZN
|
+$518M |
| 4 |
Eli Lilly
LLY
|
+$268M |
| 5 |
UnitedHealth
UNH
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.51% |
| 2 | Technology | 14.39% |
| 3 | Financials | 11.76% |
| 4 | Consumer Discretionary | 9.46% |
| 5 | Real Estate | 8.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SIRE
2651
DELISTED
Sisecam Resources LP
SIRE
| $878K | ﹤0.01% |
+33,418
| New | +$873K |
|
|
DRNA
2652
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $871K | ﹤0.01% |
71,100
-218,300
| -75% | -$2.74M |
|
2653
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.13B
| $869K | ﹤0.01% |
9,200
+3,400
| +59% | +$312K |
|
|
ATHX
2654
DELISTED
Athersys, Inc. Common Stock
ATHX
| $867K | ﹤0.01% |
17,596
+3,084
| +21% | +$168K |
|
2655
Vanguard Consumer Discretionary ETF
VCR
$5.97B
| $865K | ﹤0.01% |
5,100
+3,800
| +292% | +$628K |
|
|
TRIL
2656
DELISTED
Trillium Therapeutics Inc.
TRIL
| $864K | ﹤0.01% |
144,000
+102,300
| +245% | +$652K |
|
|
UBP
2657
DELISTED
Urstadt Biddle Properties Inc.
UBP
| $861K | ﹤0.01% |
47,100
+1,500
| +3% | +$25.8K |
|
2658
Highway Holdings
HIHO
$5M
| $860K | ﹤0.01% |
186,200
+21,302
| +13% | +$104K |
|
|
DVD
2659
DELISTED
Dover Motorsports
DVD
| $853K | ﹤0.01% |
379,000
+9,500
| +3% | +$19.9K |
|
2660
Schwab US Mid-Cap ETF
SCHM
$14.2B
| $851K | ﹤0.01% |
46,500
+29,400
| +172% | +$532K |
|
|
MSB
2661
Mesabi Trust
MSB
$296M
| $845K | ﹤0.01% |
34,400
+21,400
| +165% | +$525K |
|
|
EPE
2662
DELISTED
EP Energy Corporation
EPE
| $844K | ﹤0.01% |
+281,400
| New | +$671K |
|
2663
Delek Logistics
DKL
$3.12B
| $843K | ﹤0.01% |
+30,500
| New | +$874K |
|
2664
Corbus Pharmaceuticals
CRBP
$165M
| $842K | ﹤0.01% |
+5,561
| New | +$1.01M |
|
|
KL
2665
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $841K | ﹤0.01% |
39,700
-95,900
| -71% | -$1.76M |
|
|
MLVF
2666
DELISTED
Malvern Bancorp, Inc.
MLVF
| $836K | ﹤0.01% |
34,352
+5,277
| +18% | +$135K |
|
|
GENE
2667
DELISTED
Genetic Technologies Ltd.
GENE
| $833K | ﹤0.01% |
42,096
-7,053
| -14% | -$167K |
|
2668
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.6B
| $832K | ﹤0.01% |
14,800
+6,800
| +85% | +$380K |
|
2669
Vanguard FTSE Pacific ETF
VPL
$7.77B
| $828K | ﹤0.01% |
+11,827
| New | +$860K |
|
2670
Eagle Bancorp
EGBN
$850M
| $826K | ﹤0.01% |
+13,480
| New | +$819K |
|
|
ESND
2671
DELISTED
Essendant Inc.
ESND
| $826K | ﹤0.01% |
62,500
+4,678
| +8% | +$52.9K |
|
2672
Curis
CRIS
$9.71M
| $822K | ﹤0.01% |
1,187
-788
| -40% | -$807K |
|
|
SALM
2673
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
| $822K | ﹤0.01% |
159,700
-18,400
| -10% | -$70.1K |
|
|
DNBF
2674
DELISTED
DNB Financial Corp
DNBF
| $820K | ﹤0.01% |
23,400
+8,302
| +55% | +$291K |
|
2675
Vicor
VICR
$8.33B
| $819K | ﹤0.01% |
18,800
-189,200
| -91% | -$7.32M |
|
Similar funds
Renaissance Technologies's Q2 2018 Portfolio in Review
As of Q2 2018, Renaissance Technologies held 3,750 positions worth $91.7B, up 0.34% from $91.4B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Renaissance Technologies withdrew a net $3.9B in Q2 2018, closing 524 positions and reducing 1,111 holdings. Its most notable exit was Booking.com, an estimated $519M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Financials.
Against the trend, Renaissance Technologies opened a new position in Apple worth $707M.
- Renaissance Technologies's largest Q2 2018 buy was Apple: 15,275,332 shares worth $707M.
- Renaissance Technologies added most to Johnson & Johnson in Q2 2018, an estimated $306M increase.
- Renaissance Technologies's biggest Q2 2018 reduction was Home Depot, cutting an estimated $596M.
- Renaissance Technologies fully exited Booking.com in Q2 2018, selling an estimated $519M.
- Renaissance Technologies's ten largest holdings make up 9.1% of its $91.7B portfolio in Q2 2018.
- Renaissance Technologies opened 412 new positions and closed 524 in Q2 2018.
- Renaissance Technologies's portfolio value rose 0.34% quarter-over-quarter to $91.7B.
Based on Renaissance Technologies's 13F filing for Q2 2018, filed 13 Aug 2018.